Steven Kaufman discusses the return of sustainability to the centre of drug delivery conversation and how Eco-Inject’s novel autoinjector brings fresh thinking to the sector.
We spoke with Steven Kaufman of Eco-inject at Pharmapack 2026 about what is shaping pharma and device innovation in 2026. With hundreds of millions of GLP-1 devices in use, sustainability is firmly back at the centre of the conversation. The challenge now is balancing that focus alongside priorities such as connectivity, while ensuring that suppliers can clearly articulate the real value of their solutions. After years of incremental change in auto-injectors, Eco-Inject has the potential to shift the paradigm, provided the industry raises the bar on transparency, data and impact.
